Digital Ally, Inc. (NASDAQ: DGLY), which develops, manufactures and
markets advanced video recording products for law enforcement,
emergency management, fleet safety and security, today announced it
has partnered with Trust Think Products, LLC a De Soto, KS-based
company that is the exclusive distributor of the Danolyte®
disinfectant. Danolyte, is a one-step disinfectant cleaner designed
for cleaning and disinfecting hard, non-porous environmental
surfaces in health-care facilities. Danolyte has demonstrated
effectiveness against viruses similar to SARS-CoV-2 on hard porous
and/or non-porous surfaces and has been listed on the EPA’s List N:
Disinfectants for Use Against SARS-CoV-2, the virus that causes the
novel COVID-19 disease also known as the coronavirus. Additional
information can be found by clicking here.
Danolyte disinfectant is a powerful
antimicrobial fluid for use across a broad spectrum of
applications, yet gentle enough for use on baby toys. The Danolyte
disinfectant offers disinfection, sanitizing and deodorizing
solutions for many industries other than first responders including
water treatment, agriculture, oil and gas, healthcare, education,
and food service/processing. It has been shown effective over many
years of use and is effective over a broad range of viruses and
bacteria such as the coronavirus, MRSA, HIV, Listeria, Influenza A,
Hepatitis C and Salmonella among many others.
In response to the coronavirus pandemic the two
companies have partnered to provide first responders with the
Danolyte to disinfect workspaces like patrol vehicles, ambulances
and other surfaces with no harsh chemicals, harsh fumes, or
chemical residuals.
Stan Ross, CEO of Digital Ally, Inc., stated
“Amid the coronavirus pandemic, we have partnered with Trust Think
Products to provide first responders with vital disinfecting
products that they can trust to provide defenses against the spread
of the coronavirus disease as well as many others. The ultimate
goal is to use our existing relationships to provide
first-responders and others with the safest working space possible
during this time and we are confident this partnership will help
achieve this goal,” concluded Mr. Ross.
Joe Bisogno, CEO Trust Think Products, stated
“With over 15 years of working with first responders, including
EMS, taxi-cab, hospital paratransit, law enforcement officers as
well as many commercial fleets, Digital Ally will be able to help
expedite distribution of the highly effective cleaning solution
needed to eliminate the coronavirus among many other viruses and
bacteria. We are excited to work with such a respected company in
Digital Ally, Inc.,” concluded Bisogno.
Customers are encouraged to visit the Company
website at www.digitalallyinc.com, or contact the Company at
800-440-4947 to obtain further information and to order the
Danolyte product.
Digital Ally Fourth Quarter and Year-End Operating
Results Conference Call
Digital Ally will host an investor conference
call on Monday, April 6, 2020 at 11:15 a.m. eastern time to discuss
its operating results for fourth quarter and the year ended
December 31, 2019. Shareholders and other interested parties may
participate in the conference call by dialing (844) 761-0863 and
entering conference ID #3474957 a few minutes before 11:15 a.m.
Eastern on Monday, April 6, 2020.
About Digital AllyDigital
Ally®, headquartered in Lenexa, KS, specializes in the design and
manufacturing of the highest quality video recording equipment and
video analytic software. Digital Ally pushes the boundaries of
technology in industries such as law enforcement, emergency
management, fleet safety and security. Digital Ally’s complete
product solutions include vehicle and body cameras, flexible
software storage, and automatic recording technology. These
products work seamlessly together and are simple to install and
operate. Digital Ally products are sold by domestic direct sales
representatives and international distributors worldwide.
About Think Trust, Inc. Trust
Think, Inc. located in Desoto, KS, collaborates with scientists,
researchers, doctors and veterinarians to develop and distribute
all-natural products designed to improve the health and well-being
of people, pets, livestock and wildlife.
For additional news and information please visit
www.digitalallyinc.com or follow additional Digital Ally Inc.
social media channels here:
Facebook I Instagram I Linkedin I Twitter
Contact InformationStanton Ross, CEOTom
Heckman, CFODigital Ally,
Inc913-814-7774info@digitalallyinc.com
This press release contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Act of 1934. These
forward-looking statements are based largely on the expectations or
forecasts of future events, can be affected by inaccurate
assumptions, and are subject to various business risks and known
and unknown uncertainties, a number of which are beyond the control
of management. Therefore, actual results could differ materially
from the forward-looking statements contained in this press
release. A wide variety of factors that may cause actual results to
differ from the forward-looking statements include, but are not
limited to, the following: whether the Company will effectively
manage the disruptions to its supply chain and business activities
caused by the coronavirus including when it will cease to impact
our business and the results of our operations; whether the
Company will be able to effectively market and distribute the
Danolyte® product to its first-responder and other customers;
whether the Company can acquire the Danolyte® product in the
quantities and timing necessary to serve its customers; whether the
Company will be able to distribute the Danolyte® product in a
cost-effective, profitable manner; whether the Danolyte® will be
proven effective against the coronavirus as claimed by its
manufacturer; whether the Company will be able to maintain or
expand its share of the markets in which it competes with the new
EVO-HD; whether and the extent to which customers will accept the
new platform of products being developed with the EVO-HD system
with the Company’s VuLink® technology; whether the Company will be
able to adapt its technology to new and different uses, including
being able to introduce new products; competition from larger, more
established companies with far greater economic and human
resources; its ability to attract and retain customers and quality
employees; the effect of changing economic conditions; and changes
in government regulations, tax rates and similar matters and
whether the Company will be successful in its patent infringement
litigation with Axon Enterprises, Inc. These cautionary statements
should not be construed as exhaustive or as any admission as to the
adequacy of the Company's disclosures. The Company cannot predict
or determine after the fact what factors would cause actual results
to differ materially from those indicated by the forward-looking
statements or other statements. The reader should consider
statements that include the words "believes", "expects",
"anticipates", "intends", "estimates", "plans", "projects",
"should", or other expressions that are predictions of or indicate
future events or trends, to be uncertain and forward-looking. The
Company does not undertake to publicly update or revise
forward-looking statements, whether as a result of new information,
future events or otherwise. Additional information respecting
factors that could materially affect the Company and its operations
are contained in its annual report on Form 10-K for the year ended
December 31, 2019, which will be filed with the Securities and
Exchange Commission on or about April 6, 2020.
Digital Ally (NASDAQ:DGLY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Digital Ally (NASDAQ:DGLY)
Historical Stock Chart
From Apr 2023 to Apr 2024